Molecular Partners AG
MLLCF
$4.22
-$0.06-1.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 787.30K | 1.72M | 3.13M | 1.17M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 787.30K | 1.72M | 3.13M | 1.17M |
| Cost of Revenue | 10.76M | 12.56M | 14.47M | 16.13M | 13.45M |
| Gross Profit | -10.76M | -11.77M | -12.76M | -13.00M | -12.29M |
| SG&A Expenses | 6.09M | 5.09M | 4.91M | 5.14M | 6.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.85M | 17.65M | 19.38M | 21.27M | 19.97M |
| Operating Income | -16.85M | -16.87M | -17.67M | -18.14M | -18.80M |
| Income Before Tax | -12.79M | -18.97M | -16.68M | -12.95M | -22.34M |
| Income Tax Expenses | 2.30K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.79M | -18.97M | -16.68M | -12.95M | -22.34M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.79M | -18.97M | -16.68M | -12.95M | -22.34M |
| EBIT | -16.85M | -16.87M | -17.67M | -18.14M | -18.80M |
| EBITDA | -16.57M | -16.18M | -17.00M | -17.45M | -18.54M |
| EPS Basic | -0.35 | -0.57 | -0.50 | -0.39 | -0.68 |
| Normalized Basic EPS | -0.22 | -0.36 | -0.31 | -0.25 | -0.42 |
| EPS Diluted | -0.35 | -0.57 | -0.50 | -0.39 | -0.68 |
| Normalized Diluted EPS | -0.22 | -0.36 | -0.31 | -0.25 | -0.42 |
| Average Basic Shares Outstanding | 36.88M | 33.19M | 33.18M | 32.87M | 32.86M |
| Average Diluted Shares Outstanding | 36.88M | 33.19M | 33.18M | 32.87M | 32.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |